Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Sponsored by: Cardiology Grand Rounds Academic Year 2013-2014 Hypertrophic Cardiomyopathy Registry (HCMR) – Novel Predictors of Outcome in HCM Thursday, January 9, 2014 7:30 – 8:30 AM 11-146 Conference Room, SCTR Christopher M. Kramer, M.D. Ruth C. Heede Professor of Cardiology Professor of Radiology and Medical Imaging University of Virginia School of Medicine Target Audience This program has been designed for departmental/institutional faculty, fellows, residents, medical students, nurses, and QA/CEQI personnel in the medical specialties of cardiology, CT surgery, radiology, cv imaging, and medicine, biology engineering, pharmacology, and physiology. Educational Objectives After completing this activity, participants should be able to: Describe evidence supporting the latest treatment for cardiac conditions (ie., interventional procedures such as cardiac catheterization, cardiac biopsies, electrophysiologic studies), noninvasive cardiac procedures and clinical cardiology therapy Recognize the importance of system-based practices that explicitly depict the larger context and system of health care by stressing the importance of collaborative efforts involving physicians and ancillary staff for safety and quality improvements Assess patient care through discussing medical errors, complications and unanticipated outcomes Improve practice through viewing records, specifics and revisiting errors to gain insight without blame or derision Review experimental data from translational and clinical studies with the potential to influence practice Assess the results of clinical trials from a regional and national view Accreditation The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Designation of Credit The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgement of Commercial Support* - NONE For more information, please contact Denice Susini 215-746-4635 [email protected] Check your CME online at www.penncmeonline.com Disclosure of Relevant Financial Relationships and Unapproved Uses of Products It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner. The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations. The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, Director of CME and the peer reviewer Zalman Agus, MD, Associate Dean for CME, have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity. The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity: PLANNING COMMITTEE MEMBER NAME MICHAEL PARMACEK, MD BENJAMIN D’SOUZA, MD VICTOR FERRARI, MD PRESENTER NAME The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity. PLANNING COMMITTEE MEMBER NAME Lee Goldberg, MD NAME OF COMMERCIAL INTEREST Thoratec & Medtronic RELATIONSHIP Consultant PRESENTER NAME Christopher Kramer, MD NAME OF COMMERCIAL INTEREST Siemens Healthcare Synarc RELATIONSHIP PI Consultant Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected DISCLOSURE OF UNAPPROVED USES OF PRODUCTS PRESENTER NAME Christopher Kramer, MD PRODUCT Gadolinium contrast INVESTIGATIONAL AND/OR OFF-LABEL USE use in the heart